Sjögrens syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB

Genes and Immunity

Volumn 13, Issue 5, 2012, Pages 411-420

  Sisto, M ^a   Lisi, S ^a   Lofrumento, D D ^b   D'amore, M ^c   Frassanito, M A ^c   Ribatti, D ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF SALENTO   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

NF B; Sj gren's syndrome; TACE; VEGF A; VEGFR2

Indexed keywords

ANGIOGENIC FACTOR; AUTOANTIBODY; BETA 2 MICROGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RO ANTIBODY; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA CONVERTING ENZYME; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; ADAM PROTEIN; CYTOKINE; TUMOR NECROSIS FACTOR-ALPHA CONVERTASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; MALE; MOLECULAR INTERACTION; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SALIVARY GLAND EPITHELIAL CELL; SJOEGREN SYNDROME; WESTERN BLOTTING; ANIMAL; CASE CONTROL STUDY; CHICK EMBRYO; CHORIOALLANTOIS; DRUG EFFECT; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; SECRETION (PROCESS); SIGNAL TRANSDUCTION; VASCULARIZATION;

ADAM PROTEINS; ADULT; AGED; ANIMALS; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; CYTOKINES; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; SIGNAL TRANSDUCTION; SJOGREN'S SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84864146262     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2012.9     Document Type: Article

References (36)

1. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L. VEGF receptor signalling-in control of vascular function. Nat Rev Mol Cell Biol 2006; 7: 359-371.
2. Carvalho JF, Blank M, Shoenfeld Y. Vascular endothelial growth factor (VEGF) in autoimmune diseases. J Clin Immunol 2007; 27: 246-256. (Pubitemid 46790822)
3. D'Amore PA. Ng YS.Won't you be my neighbor? Local induction of arteriogenesis. Cell 2002; 110: 289-292.
4. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995; 1: 27-31.
5. Roy R, Zhang B, Moses MA. Making the cut: protease-mediated regulation of angiogenesis. Exp Cell Res 2006; 312: 608-622. (Pubitemid 43290337)
6. Rundhaug JE. Matrix metalloproteinases and angiogenesis. J Cell Mol Med 2005; 9: 267-285.
7. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA. Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004; 56: 549-580. (Pubitemid 39658463)
8. Weskamp G, Mendelson K, Swendeman S, Le Gall S, Ma Y, Lyman S et al. Pathological neovascularization is reduced by inactivation of ADAM17 in endothelial cells but not in pericytes. Circ Res 2010; 106: 932-940.
9. Shi W, Chen H, Sun J, Buckley S, Zhao J, Anderson KD et al. TACE is required for fetal murine cardiac development and modeling. Dev Biol 2003; 261: 371-380. (Pubitemid 37108781)
10. Swendeman S, Mendelson K, Weskamp G, Horiuchi K, Deutsch U, Scherle P et al. VEGF-A stimulates ADAM17-dependent shedding of VEGFR2 and crosstalk between VEGFR2 and ERK signalling. Circ Res 2008; 103: 916-918.
11. Roescher N, Tak PP, Illei GG. Cytokines in Sjö gren's syndrome. Oral Dis 2009; 15: 519-526.
12. Fox RI, Kang HI, Ando D, Abrams J, Pisa E. Cytokine mRNA expression in salivary gland biopsies of Sjogren's syndrome. J Immunol 1994; 152: 5532-5539. (Pubitemid 24153003)
13. Pflugfelder SC, Jones D, Ji Z, Afonso A, Monroy D. Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjö gren's syndrome keratoconjunctivitis sicca. Curr Eye Res 1999; 19: 201-211. (Pubitemid 29500267)
14. Ackermann C, Kavanaugh A. Tumor necrosis factor as a therapeutic target of rheumatologic disease. Expert Opin Ther Targets 2007; 11: 1369-1384. (Pubitemid 350200476)
15. Furst DE, Schiff MH, Fleischmann RM, Strand V, Birbara CA, Compagnone D et al. Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis). J Rheumatol 2003; 30: 2563-2571. (Pubitemid 37549331)
16. Pammer J, Weninger W, Mildner M, Burian M, Wojta J, Tschachler E. Vascular endothelial growth factor is constitutively expressed in normal human salivary glands and is secreted in the saliva of healthy individuals. J Pathol 1998; 186: 186-191. (Pubitemid 28467829)
17. Coward WR, Yoshimichi O, Sagara H, Wilson SJ, Holgate ST, Church MK. NF-kB and TNF-alpha: a positive autocrine loop in human lung mast cells? J Immunol 2002; 169: 5287-5293. (Pubitemid 35217201)
18. Bauvois B. Transmembrane proteases in cell growth and invasion: new contributors to angiogenesis? Oncogene 2004; 23: 317-329. (Pubitemid 38174985)
19. Sakamoto K, Maeda S, Hikiba Y, Nakagawa H, Hayakawa Y, Shibata W et al. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 2009; 15: 2248-2258.
20. Takahashi H, Shibuya M. The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci 2005; 109: 227-241. (Pubitemid 41337127)
21. Nagashima M, Wauke K, Hirano D, Ishigami S, Aono H, Takai M et al. Effects of combinations of anti-rheumatic drugs on the production of vascular endothelial growth factor and basic fibroblast growth factor in cultured synoviocytes and patients with rheumatoid arthritis. Rheumatology (Oxford) 2000; 39: 1255-1262.
22. Szyszko EA, Brokstad KA, Oijordsbakken G, Jonsson MV, Jonsson R, Skarstein K. Salivary glands of primary Sjö gren's syndrome patients express factors vital for plasma cell survival. Arthritis Res Ther 2011; 13: R2.
23. Manzo A, Bugatti S, Caporali R, Prevo R, Jackson DG, Uguccioni M et al. CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis. Am J Pathol 2007; 171: 1549-1562. (Pubitemid 350158316)
24. Ribatti D, Nico B, Vacca A, Presta M. The gelatin sponge-chorioallantoic membrane assay. Nat Protcols 2006; 1: 85-91.
25. Gö oz P, Gö oz M, Baldys A, Hoffman S. ADAM-17 regulates endothelial cell morphology, proliferation, and in vitro angiogenesis. Biochem Biophys Res Commun 2009; 380: 33-38.
26. Sisto M, Lisi S, Lofrumento DD, Frassanito MA, Cucci L, D'Amore S et al. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies. Int Immunol 2009; 21: 1341-1349.
27. Tabruyn SP, Griffioen AW. NF-kappa B: a new player in angiostatic therapy. Angiogenesis 2008; 11: 101-106.
28. Zhang J, Peng B. NF-kappaB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro. Cell Prolif 2009; 42: 1501-1506.
29. Bharti AC, Aggarwal BB. Nuclear factor-kappa B and cancer: its role in prevention and therapy. Biochem Pharmacol 2002; 64: 883-888. (Pubitemid 35238030)
30. Sisto M, Lisi S, Lofrumento DD, Ingravallo G, Maiorano E, D'Amore M. A failure of TNFAIP3 negative regulation maintains sustained NF-kB activation in Sjö gren's syndrome. Histochem Cell Biol 2011; 135: 615-625.
31. Szekanecz Z, Besenyei T, Paragh G, Koch AE. Angiogenesis in rheumatoid arthritis. Autoimmunity 2009; 42: 563-573.
32. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE et al. Classification criteria for Sjö gren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. European Study Group on Classification Criteria for Sjö gren's Syndrome. Ann Rheum Dis 2002; 61: 554-558. (Pubitemid 34539104)
33. Sens DA, Hintz DS, Rudisill MT, Sens MA, Spicer SS. Explant culture of human submandibular gland epithelial cells: evidence for ductal origin. Lab Invest 1985; 52: 559-567. (Pubitemid 15065730)
34. Kapsogeorgou EK, Dimitriou ID, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Activation of epithelial and myoepithelial cells in the salivary glands of patients with Sjö gren's syndrome: high expression of intercellular adhesion molecule-1 (ICAM.1) in biopsy specimens and cultured cells. Clin Exp Immunol 2001; 124: 126-133. (Pubitemid 32476942)
35. Lisi S, Sisto M, Lofrumento DD, Cucci L, Frassanito MA, Mitolo V et al. Proinflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis. J Autoimmun 2010; 35: 160-170.
36. Sisto M, Lisi S, Castellana D, Scagliusi P, D'Amore M, Caprio S et al. Autoantibodies from Sjö gren's syndrome induce activation of both the intrinsic and extrinsic apoptotic pathways in human salivary gland cell line A-253. J Autoimmun 2006; 27: 38-49. (Pubitemid 44294853)